Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus
NCT00108004
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
400
Enrollment
INDUSTRY
Sponsor class
Conditions
Type 1 Diabetes Mellitus
Type 2 Diabetes Mellitus
Interventions
DRUG:
pramlintide acetate
Sponsor
AstraZeneca